Clinical Trials Logo

Clinical Trial Summary

The present study will use a within-person, randomized cross-over experimental design to test the effects of exogenous melatonin supplementation on the sleep and daytime functioning of typically developing adolescents with short or disrupted sleep of behavioral origins (i.e., difficulty falling asleep, staying asleep, or premature waking resulting in short or disrupted sleep not attributed to an organic sleep condition).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04588233
Study type Interventional
Source Loma Linda University
Contact Brooke Iwamoto
Phone 909-558-7412
Email biwamoto@llu.edu
Status Recruiting
Phase N/A
Start date September 15, 2021
Completion date December 2024

See also
  Status Clinical Trial Phase
Recruiting NCT06367400 - Validation of Pediatric Sleep Questionnaire on a Swedish Cohort
Completed NCT03224455 - Environmental Assessment of Sleep in Youth
Active, not recruiting NCT05382494 - Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children Phase 4